Perceptive Advisors LLC Sage Therapeutics, Inc. Transaction History

Perceptive Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$70.65 - $96.76 $31.1 Million - $42.6 Million	-440,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$58.41 - $89.06 $25.7 Million - $39.2 Million	440,000 New	440,000 $38.1 Million
Q1 2019 May 15, 2019	SELL	$89.33 - $163.65 $13.2 Million - $24.1 Million	-147,315 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$81.94 - $139.71 $12.1 Million - $20.6 Million	147,315 New	147,315 $13.1 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $303M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.